Endocrinology Specialist With Academic Focus on GLP-1 and Metabolic Medicine

Dr. Jeppe Skov is a Danish physician and endocrinology specialist. His academic and clinical work centers on metabolic medicine, GLP-1-based therapy, obesity medicine, type 2 diabetes, hormonal regulation of metabolism, and kidney-function considerations relevant to incretin-based treatment.

Dr. Skov studied medicine at Aarhus University and completed doctoral research focused on GLP-1 treatment and kidney function. His academic background is relevant to patient-facing medical content involving GLP-1 receptor agonists, metabolic health, weight management, diabetes overlap, and renal physiology.

For SunnyPharma^®, Dr. Skov is listed as a Medical Reviewer for endocrinology and metabolic-medicine content. His reviewer profile is presented to help readers understand the clinical and academic background behind medical review of weight-management and GLP-1-related health education.

Education and Specialist Training

• 🎓
  Medicine — Aarhus University

  Medical education completed at Aarhus University.

  Medical Education
• 🎓
  PhD Research — GLP-1 Treatment and Kidney Function

  Doctoral work focused on the effect of GLP-1 treatment on kidney function.

  Doctoral Research
• 🎓
  Specialist Training — Endocrinology

  Specialist background in diabetes, hormone medicine, metabolic disease, and endocrinology.

  Specialist Training

Academic Focus

Dr. Skov’s academic focus includes GLP-1 pharmacology, incretin-based therapy, kidney-function effects of metabolic treatment, obesity medicine, type 2 diabetes, and the endocrine mechanisms involved in weight regulation and cardiometabolic risk.

• 📄
  GLP-1-Based Therapy

  Academic and clinical work related to glucagon-like peptide-1 treatment and metabolic outcomes.

  Research Area
• 📄
  Kidney Function and Metabolic Treatment

  Doctoral focus on the relationship between GLP-1 treatment and renal physiology.

  Research Area
• 📄
  Obesity, Diabetes, and Metabolic Health

  Clinical endocrinology focus relevant to obesity-related comorbidity, diabetes overlap, and long-term metabolic risk.

  Clinical Focus